Evidence map›Paper›PMID 36075047›Full record

ArticleLeukemia & lymphoma2022

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Konstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing-Zhou Hou, Rafic Farah, Robert L Redner, Annie Im, Kathleen A Dorritie, Alison Sehgal and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia & lymphoma, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Konstantinos LontosUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-0216-3818
Anastasia TsagianniUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Mounzer AghaUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Anastasios RaptisUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Jing-Zhou HouUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Rafic FarahUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Robert L RednerUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Annie ImUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Kathleen A DorritieUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Alison SehgalUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-3954-7401
James RossettiUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Nidhi AggarwalDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Melissa SaulDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
William GoodingBiostatistics Facility, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Michael BoyiadzisUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
NRSA Training CoreTL1TR001858 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RADOMSKI, THOMAS, RUBIO, DORIS M · 2016 to 2025
$11.1M
NCATS NIH HHS TL1 TR001858NCI NIH HHS P30 CA047904
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Induction ChemotherapyLeukemia, Myeloid, AcuteCytogenetic AnalysisCytogeneticsfms-Like Tyrosine Kinase 3HumansMutationNomogramsNuclear ProteinsPrognosisTumor Suppressor Protein p53fms-Like Tyrosine Kinase 3Nuclear ProteinsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID36075047
PMCPMC9771947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.